{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:32:09Z","timestamp":1792373529396,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.vaccine.2022.06.046","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T07:23:35Z","timestamp":1656314615000},"page":"4732-4741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a virus-like particles induces a protective immune response against porcine circovirus type 2 in mice"],"prefix":"10.1016","volume":"40","author":[{"given":"Yu-an","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanni","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huoying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2022.06.046_b0005","doi-asserted-by":"crossref","first-page":"e1007562","DOI":"10.1371\/journal.ppat.1007562","article-title":"Structural roles of PCV2 capsid protein N-terminus in PCV2 particle assembly and identification of PCV2 type-specific neutralizing epitope","volume":"15","author":"Mo","year":"2019","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.046_b0010","doi-asserted-by":"crossref","DOI":"10.1186\/1297-9716-45-13","article-title":"Effect of porcine circovirus type 2 (PCV2) vaccination on PCV2-viremic piglets after experimental PCV2 challenge","volume":"45","author":"Seo","year":"2014","journal-title":"Vet Res"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.046_b0015","first-page":"153","article-title":"Characterization of papovavirus-and picornavirus-like particles in permanent pig kidney cell lines","volume":"226","author":"Tischer","year":"1974","journal-title":"Zentralbl Bakteriol Orig A"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.046_b0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/v14020261","article-title":"Novel Porcine Circoviruses in View of Lessons Learned from Porcine Circovirus Type 2-Epidemiology and Threat to Pigs and Other Species","volume":"14","author":"Turlewicz-Podbielska","year":"2022","journal-title":"Viruses"},{"issue":"3-4","key":"10.1016\/j.vaccine.2022.06.046_b0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.vetmic.2009.09.056","article-title":"Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination","volume":"142","author":"Opriessnig","year":"2010","journal-title":"Vet Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2022.06.046_b0030","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1128\/CVI.05027-11","article-title":"Effects of an Inactivated Porcine Circovirus Type 2 (PCV2) Vaccine on PCV2 Virus Shedding in Semen from Experimentally Infected Boars","volume":"18","author":"Seo","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2022.06.046_b0035","doi-asserted-by":"crossref","unstructured":"Ferrari L, Borghetti P, De Angelis E, Martelli P. Memory T cell proliferative responses and IFN-gamma productivity sustain long-lasting efficacy of a Cap-based PCV2 vaccine upon PCV2 natural infection and associated disease. VET RES 2014 2014-04-16;45:44.","DOI":"10.1186\/1297-9716-45-44"},{"issue":"45","key":"10.1016\/j.vaccine.2022.06.046_b0040","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1016\/j.vaccine.2021.07.043","article-title":"Protective immunity induced by concurrent intradermal injection of porcine circovirus type 2 and Mycoplasma hyopneumoniae inactivated vaccines in pigs","volume":"39","author":"Lee","year":"2021","journal-title":"Vaccine"},{"issue":"39","key":"10.1016\/j.vaccine.2022.06.046_b0045","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1016\/j.vaccine.2021.08.013","article-title":"Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a\/PCV2b) and challenge with virulent PCV2d","volume":"39","author":"Venegas-Vargas","year":"2021","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2022.06.046_b0050","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3390\/pathogens10091161","article-title":"Non-Assembled ORF2 Capsid Protein of Porcine Circovirus 2b Does Not Confer Protective Immunity","volume":"10","author":"Guarneri","year":"2021","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.vaccine.2022.06.046_b0055","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/SHK.0000000000000211","article-title":"Delayed Neutralization of Interleukin 6 Reduces Organ Injury, Selectively Suppresses Inflammatory Mediator, and Partially Normalizes Immune Dysfunction Following Trauma and Hemorrhagic Shock","volume":"42","author":"Zhang","year":"2014","journal-title":"SHOCK"},{"issue":"5214","key":"10.1016\/j.vaccine.2022.06.046_b0060","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1126\/science.7761837","article-title":"T helper cell subsets in insulin-dependent diabetes","volume":"268","author":"Katz","year":"1995","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.vaccine.2022.06.046_b0065","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1002\/eji.200636760","article-title":"Anti-cytokine vaccines and the immunotherapy of autoimmune diseases","volume":"36","author":"Wraith","year":"2006","journal-title":"Eur J Immunol"},{"issue":"7-8","key":"10.1016\/j.vaccine.2022.06.046_b0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0167-5699(87)90171-X","article-title":"Two types of mouse helper T-cell clone Implications for immune regulation","volume":"8","author":"Mosmann","year":"1987","journal-title":"Immunol Today"},{"issue":"10","key":"10.1016\/j.vaccine.2022.06.046_b0075","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00705-020-04754-9","article-title":"Efficient application of a baculovirus-silkworm larvae expression system for obtaining porcine circovirus type 2 virus-like particles for a vaccine","volume":"165","author":"He","year":"2020","journal-title":"Arch Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2022.06.046_b0080","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.vaccine.2016.02.047","article-title":"Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B","volume":"34","author":"Hu","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.046_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2018.00232","article-title":"Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface","volume":"8","author":"Wang","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.046_b0090","first-page":"26","article-title":"Cutting Edge: Limited Specialization of Dendritic Cell Subsets for MHC Class II-Associated Presentation of Viral Particles","volume":"184","author":"Keller","year":"2010","journal-title":"JI"},{"issue":"27","key":"10.1016\/j.vaccine.2022.06.046_b0095","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1016\/j.vaccine.2012.04.022","article-title":"Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition","volume":"30","author":"Trible","year":"2012","journal-title":"Vaccine"},{"issue":"1-2","key":"10.1016\/j.vaccine.2022.06.046_b0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.virusres.2011.11.018","article-title":"Genetic variation of porcine circovirus type 2 (PCV2) and its relevance to vaccination, pathogenesis and diagnosis","volume":"164","author":"Trible","year":"2012","journal-title":"Virus Res"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.046_b0105","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11259-007-3469-7","article-title":"Immunogenicity of empty capsids of porcine circovius type 2 produced in insect cells","volume":"31","author":"Fan","year":"2007","journal-title":"Vet Res Commun"},{"issue":"11","key":"10.1016\/j.vaccine.2022.06.046_b0110","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.vaccine.2007.11.053","article-title":"The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex","volume":"26","author":"Fachinger","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.046_b0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pep.2013.05.009","article-title":"Use of baculovirus expression system for generation of virus-like particles: successes and challenges","volume":"90","author":"Liu","year":"2013","journal-title":"Protein Expr Purif"},{"issue":"10","key":"10.1016\/j.vaccine.2022.06.046_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140039","article-title":"Improved Production Efficiency of Virus-Like Particles by the Baculovirus Expression Vector System","volume":"10","author":"Lopez-Vidal","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.06.046_b0125","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1743-422X-7-166","article-title":"Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli","volume":"7","author":"Yin","year":"2010","journal-title":"VIROL J"},{"key":"10.1016\/j.vaccine.2022.06.046_b0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jbiotec.2016.01.017","article-title":"Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli","volume":"220","author":"Wu","year":"2016","journal-title":"J Biotechnol"},{"issue":"41","key":"10.1016\/j.vaccine.2022.06.046_b0135","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1016\/j.vaccine.2010.07.083","article-title":"Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype","volume":"28","author":"Ameiss","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.046_b0140","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2013350118","article-title":"Synthesis and delivery of Streptococcus pneumoniae capsular polysaccharides by recombinant attenuated Salmonella vaccines","volume":"118","author":"Su","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.046_b0145","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/IAI.00445-10","article-title":"Comparison of a Regulated Delayed Antigen Synthesis System withIn Vivo -Inducible Promoters for Antigen Delivery by Live Attenuated Salmonella Vaccines","volume":"79","author":"Wang","year":"2011","journal-title":"Infect Immun"},{"issue":"23","key":"10.1016\/j.vaccine.2022.06.046_b0150","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1016\/j.vaccine.2011.03.066","article-title":"Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine","volume":"29","author":"Ashraf","year":"2011","journal-title":"Vaccine"},{"issue":"44","key":"10.1016\/j.vaccine.2022.06.046_b0155","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1016\/j.vaccine.2020.08.062","article-title":"Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a conserved surface protein enolase induces high and broad protection against Streptococcus suis serotypes 2, 7, and 9 in mice","volume":"38","author":"Li","year":"2020","journal-title":"Vaccine"},{"issue":"39","key":"10.1016\/j.vaccine.2022.06.046_b0160","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1016\/j.vaccine.2021.08.031","article-title":"Therapeutic activity of a Salmonella-vectored Schistosoma mansoni vaccine in a mouse model of chronic infection","volume":"39","author":"Hassan","year":"2021","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2022.06.046_b0165","doi-asserted-by":"crossref","first-page":"e1006574","DOI":"10.1371\/journal.ppat.1006574","article-title":"The role of the C-terminal D0 domain of flagellin in activation of Toll like receptor 5","volume":"13","author":"Forstneri\u010d","year":"2017","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.vaccine.2022.06.046_b0170","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41590-019-0368-3","article-title":"Innate immunity to intracellular LPS","volume":"20","author":"Rathinam","year":"2019","journal-title":"Nat Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2022.06.046_b0175","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20030335","article-title":"Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivo","volume":"198","author":"Rotta","year":"2003","journal-title":"J EXP MED"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.046_b0180","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1073\/pnas.0811697106","article-title":"Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA","volume":"106","author":"Li","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.046_b0185","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-017-0494-6","article-title":"Salmonella enterica serovar Choleraesuis vector delivering SaoA antigen confers protection against Streptococcus suis serotypes 2 and 7 in mice and pigs","volume":"48","author":"Li","year":"2017","journal-title":"VET RES"},{"issue":"38","key":"10.1016\/j.vaccine.2022.06.046_b0190","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1016\/j.vaccine.2015.07.063","article-title":"Live attenuated Salmonella enterica serovar Choleraesuis vaccine vector displaying regulated delayed attenuation and regulated delayed antigen synthesis to confer protection against Streptococcus suis in mice","volume":"33","author":"Ji","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.046_b0195","first-page":"17","article-title":"Expression of antibody fragments by periplasmic secretion in Escherichia coli","volume":"308","author":"Popplewell","year":"2005","journal-title":"Methods Mol Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.046_b0200","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1128\/IAI.70.4.1739-1749.2002","article-title":"Immune Responses to Recombinant Pneumococcal PspA Antigen Delivered by Live Attenuated Salmonella enterica Serovar Typhimurium Vaccine","volume":"70","author":"Kang","year":"2002","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.046_b0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1865-1682.2010.01189.x","article-title":"Prolonged Detection of PCV2 and Anti-PCV2 Antibody in Oral Fluids Following Experimental Inoculation: Prolonged Detection of PCV2 Infection by Oral Fluid","volume":"58","author":"Prickett","year":"2011","journal-title":"Transbound Emerg Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2022.06.046_b0210","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.4142\/jvs.2020.21.e78","article-title":"The changes of immune-related molecules within the ileal mucosa of piglets infected with porcine circovirus type 2","volume":"21","author":"Shi","year":"2020","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2022.06.046_b0215","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fcimb.2019.00171","article-title":"Establishment and Characterization of an Immortalized Porcine Oral Mucosal Epithelial Cell Line as a Cytopathogenic Model for Porcine Circovirus 2 Infection","volume":"9","author":"Cui","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.046_b0220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.smim.2007.12.003","article-title":"Dynamic interactions between bacteria and immune cells leading to intestinal IgA synthesis","volume":"20","author":"Tsuji","year":"2008","journal-title":"Semin Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.06.046_b0225","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-3083.2009.02319.x","article-title":"Mucosal Immunity: Induction, Dissemination, and Effector Functions","volume":"70","author":"Brandtzaeg","year":"2009","journal-title":"Scand J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.046_b0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrmicro1343","article-title":"Coronavirus infection of the central nervous system: host\u2013virus stand-off","volume":"4","author":"Bergmann","year":"2006","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.06.046_b0235","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni0603-503","article-title":"TH1-TH2: a Procrustean paradigm","volume":"4","author":"Gor","year":"2003","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.046_b0240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"IMMUNOL REV"},{"issue":"9","key":"10.1016\/j.vaccine.2022.06.046_b0245","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3390\/pathogens10091145","volume":"10","author":"Kang","year":"2021","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.046_b0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/vim.2000.13.143","article-title":"Characterization of Immune Response of Young Pigs to Porcine Circovirus Type 2 Infection","volume":"13","author":"Pogranichnyy","year":"2000","journal-title":"Viral Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2022.06.046_b0255","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s007050170124","article-title":"Production, characterisation and applications of monoclonal antibodies to porcine circovirus 2","volume":"146","author":"McNeilly","year":"2001","journal-title":"Arch Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.06.046_b0260","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.vaccine.2020.12.013","article-title":"Evaluation of novel recombinant porcine circovirus type 2d (PCV2d) vaccine in pigs naturally infected with PCV2d","volume":"39","author":"Kim","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.046_b0265","doi-asserted-by":"crossref","first-page":"109022","DOI":"10.1016\/j.vetmic.2021.109022","article-title":"A new strategy to develop pseudorabies virus-based bivalent vaccine with high immunogenicity of porcine circovirus type 2","volume":"255","author":"Wu","year":"2021","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.046_b0270","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-020-00836-3","article-title":"Construction of polycistronic baculovirus surface display vectors to express the PCV2 Cap(d41) protein and analysis of its immunogenicity in mice and swine","volume":"51","author":"Chen","year":"2020","journal-title":"Vet Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:15:02Z","timestamp":1759403702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22008155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":54,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0264410X22008155"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.046","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a virus-like particles induces a protective immune response against porcine circovirus type 2 in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}